OncoTherics https://validator.w3.org/feed/docs/rss2.html Tumour Hypoxia OncoTherics pitches at the 14th Texas Life Science Forum 2025 GRANTS Legal & Disclaimer OncoTherics seeks SMART funding to support DMPK programme OncoTherics Poland SA AGM 2023 OncoTherics completes CMC scale up development OncoTherics secures 2.32M PLN in private funding OncoTherics Poland SA first AGM Hypoxia Researchers win Nobel prize! OncoTherics CEO presenting at the PACTT Pfizer Academy 27th February 2021 OncoTherics’ CSO invited to the speak at Jagiellonian University 50th anniversary Faculty Celebration OncoTherics presenting at #GPWInnovationDay 13th October 2021 OncoTherics Poland secures 12M PLN grant funding Hypoxia signaling – Challenges and opportunities for cancer therapy Hypoxia-modifier reports encouraging tolerability New Hypoxia probe reviewed in multicellular tumour spheroid cultures (MCTSs) OncoTherics Poland S.A. Overview OncoTherics Poland updates progress at LSBC 2019, Krakow News Sitemap OncoTherics wins “best pitch” at LSBC Investor Conference, Krakow Prime Minister stops by OncoTherics exhibition stand OncoTherics forms wholly owned subsidiary in Poland OncoTherics wins RESI Innovation Challenge competition OncoTherics signs MoU with University Health Network (UHN), Toronto OncoTherics wins Innovate UK Global Feasibility Study Award OCT1002 shows promising results in prostate cancer research OncoTherics VOOM’s awareness for Pancreatic Cancer! Dr Thomas Morris joins OncoTherics as Chief Medical Officer OncoTherics signs collaboration agreement with University of Cambridge OncoTherics signs collaboration agreement with University Health Network, Toronto Professor Stephanie McKeown: Awarded Weiss Medal 2013 Chancellor George Osborne visits OncoTherics Exhibition OncoTherics presentation to the 2013 Conservative Party Conference Start-up Hub Competition OncoTherics voted BEST START-UP COMPANY at the Conservative Party Conference 2013 Home Team Research news Technology Glioma Organization Untangled Using Spatial Transcriptomic, Proteomic Profiles Elucidating the Prognostic and Therapeutic significance of TOP2A in various malignancies Multi-omics analysis reveals panoramic picture of TOP2A in pan cancer Pipeline Contact About OncoTherics to pitch at the 14th Annual Texas Life Science Forum OncoTherics visits MSKCC and MDAnderson to advance translational programme OncoTherics completes first part of DMPK equivalence programme